Legend Biotech (LEGN) is a publicly traded Healthcare sector company. As of July 13, 2026, LEGN trades at $26.95 with a market cap of $5.24B and a P/E ratio of 0.00. LEGN moved -0.48% today. Year to date, LEGN is +25.78%; over the trailing twelve months it is -31.81%. Its 52-week range spans $16.24 to $45.30. Analyst consensus is strong buy with an average price target of $57.16. Rallies surfaces LEGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
9 analysts cover LEGN: 0 strong buy, 8 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $57.16.
| Metric | Value |
|---|---|
| Price | $26.95 |
| Market Cap | $5.24B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $45.30 |
| 52-Week Low | $16.24 |
| Volume | 5.30K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
9 analysts cover LEGN: 0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $57.16.